Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Research & Development: 2016-2024

Historic Research & Development for Dianthus Therapeutics (DNTH) over the last 7 years, with Dec 2024 value amounting to $83.1 million.

  • Dianthus Therapeutics' Research & Development rose 27.19% to $32.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.2 million, marking a year-over-year increase of 71.30%. This contributed to the annual value of $83.1 million for FY2024, which is 153.05% up from last year.
  • According to the latest figures from FY2024, Dianthus Therapeutics' Research & Development is $83.1 million, which was up 153.05% from $32.8 million recorded in FY2023.
  • Dianthus Therapeutics' Research & Development's 5-year high stood at $83.1 million during FY2024, with a 5-year trough of $29.4 million in FY2022.
  • Moreover, its 3-year median value for Research & Development was $32.8 million (2023), whereas its average is $48.4 million.
  • Data for Dianthus Therapeutics' Research & Development shows a peak YoY skyrocketed of 153.05% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Dianthus Therapeutics' Research & Development stood at $29.4 million in 2022, then rose by 11.78% to $32.8 million in 2023, then soared by 153.05% to $83.1 million in 2024.